Evidence map›Paper›PMID 38162469›Full record

ArticleJournal of pharmacopuncture2023

Inhibition of Glycation End Products Formation and Antioxidant Activities of

Laura Cogoi, Carla Marrassini, Elina Malen Saint Martin, María Rosario Alonso, Rosana Filip, Claudia Anesini

Open access · diamondAbstract read
In one paragraph

Article in Journal of pharmacopuncture, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Laura CogoiPharmacognosy Unit, Department of Pharmacology, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0002-2800-3751
Carla MarrassiniPharmacognosy Unit, Department of Pharmacology, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0002-1237-1330
Elina Malen Saint MartinPharmacognosy Unit, Department of Pharmacology, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0002-5784-5894
María Rosario AlonsoInstitute of Chemistry and Drug Metabolism (IQUIMEFA), CONICET-University of Buenos Aires, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0002-6041-7153
Rosana FilipPharmacognosy Unit, Department of Pharmacology, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0003-2911-7555
Claudia AnesiniPharmacognosy Unit, Department of Pharmacology, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0002-7338-9761
Consejo Nacional de Investigaciones Científicas y Técnicas · ARUniversidad de Buenos Aires · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Methods: The antioxidant activity was assayed by the DPPH assay and the inhibition of egg yolk lipid peroxidation (ILP), and anti-AGEs activity, through the inhibition of the formation of fructosamine (IF), β-amyloid (Iβ), protein carbonylation (IC) and AGEs (IA). Polyphenols were quantified by HPLC. Results: Maximum response ± SEM For F 0.01 µg/mL IF = 42 ± 4%, IC = 17 ± 2% and for 10 µg/mL IA = 38 ± 4%, Iβ = 67 ± 7%. For L 0.1 µg/mL IF = 35 ± 2%, IC = 19 ± 2% and for 100 µg/mL IA = 26 ± 3%, Iβ = 63.04 ± 2%. The DPPH IC Conclusion: The fruits of

Indexed as

anti-AGEs activityantioxidant activityfruits extractIlex paraguariensis

Identifiers

PMID38162469
PMCPMC10739477
OpenAlexW4390077318

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.